Synergistic System for Personalized ADHD Treatment

A novel system integrating Radix Polygalae extract with AI, IoT, blockchain, and wearable technologies to provide personalized and adaptive treatment for attention-deficit hyperactivity disorder (ADHD)

The original patent disclosed a method for treating ADHD using Radix Polygalae extract. However, the treatment's effectiveness is limited by its one-size-fits-all approach, lack of real-time monitoring, and inadequate data management. The new inventive concept addresses these limitations by combining the extract with cutting-edge technologies to create a more powerful, adaptive, and personalized system

The system consists of a wearable device with a built-in sensor for monitoring ADHD symptoms, a mobile application for tracking and analyzing the symptoms, and a composition comprising an effective amount of Radix Polygalae extract. The system uses machine learning algorithms to analyze the subject's response to the treatment and adjust the dosage of the botanical extract accordingly. Additionally, the system integrates with IoT devices to monitor and analyze the subject's environment, and a blockchain-based platform for securely storing and sharing ADHD-related data. The wearable device includes a transdermal patch for administering the composition, and a sensor for monitoring the subject's response to the treatment

The new claims introduce the novel combination of Radix Polygalae extract with AI, IoT, blockchain, and wearable technologies, providing a synergistic system that is more effective, adaptive, and personalized than the original patent. The inventive step lies in the integration of these distinct technologies to create a new, more powerful system for treating ADHD

Alternative embodiments may include using different types of sensors, such as EEG or ECG, or integrating with other health-related data sources. Variations may include using different machine learning algorithms or blockchain platforms, or incorporating additional features, such as gamification or social support, to enhance user engagement and treatment adherence

The inventive concept has significant commercial potential in the healthcare industry, particularly in the ADHD treatment market. The system's personalized and adaptive approach, combined with its real-time monitoring and data management capabilities, make it an attractive solution for patients, caregivers, and healthcare providers. The market potential is substantial, with an estimated global ADHD treatment market size of over $10 billion by 2025